Vimarsana
Biggest News Aggregation in the World

Yates Network News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Yates Network. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Yates Network Today - Breaking & Trending Today

Vaxxas Awarded US$3.67 million (AU$5.4 million) from global charitable foundation, Wellcome, for Human Clinical Study of Typhoid Vaccination using Needle-Free Vaccine Patch - Vimarsana News

Vaxxas Awarded US$3.67 million (AU$5.4 million) from global charitable foundation, Wellcome, for Human Clinical Study of Typhoid Vaccination using Needle-Free Vaccine Patch

Published: August 24, 2023

CAMBRIDGE, Mass. & BRISBANE, Queensland, Australia--(BUSINESS WIRE)--Vaxxas, a clinical-stage biotechnology company commercializing a novel vaccination platform, today announced that the global

Source: ibtimes.com.au
Related Topics:
United KingdomUnited StatesGyun KimKathryn MorrisJeannies PakChanghyun JinDavidl HoeyPierre BalardAmy MillerJaeyong AhnWorld Health OrganizationInternational Vaccine InstituteOneventures Innovation FundUniversity Of QueenslandWellcome Media OfficeDevelopment AuthorityCommunications TeamSenior ResearchAustralian Government Innovation Investment FundYates NetworkMelinda Gates FoundationUnited States Biomedical Advanced ResearchSalmonella TyphiSenior Research ManagerMelinda Gates
Vaxxas Awarded US$3.67 million (AU$5.4 million) from global charitable foundation, Wellcome, for Hum - Vimarsana News

Vaxxas Awarded US$3.67 million (AU$5.4 million) from global charitable foundation, Wellcome, for Hum

Published: August 24, 2023

Funding from Wellcome will further broaden Vaxxas’ diverse clinical pipeline of next-generation vaccines to include Typhoid fever.Program will be jointly developed in collaboration with SK bioscience, a global leader in vaccine development.CAMBRIDGE, Mass. & BRISBANE, Queensland, Australia--(BUSINESS WIRE)--Vaxxas,...

Source: pharmiweb.com
Related Topics:
United StatesUnited KingdomChanghyun JinJeannies PakGyun KimDavidl HoeyAmy MillerKathryn MorrisPierre BalardJaeyong AhnWorld Health OrganizationInternational Vaccine InstituteWellcome Media OfficeUnited States Biomedical Advanced ResearchDevelopment AuthorityOneventures Innovation FundCommunications TeamMelinda Gates FoundationYates NetworkAustralian Government Innovation Investment FundUniversity Of QueenslandSenior ResearchSalmonella TyphiSenior Research ManagerMelinda Gates
Ajax Therapeutics Appoints Dr. David Steensma as Chief Medical Officer - Vimarsana News

Ajax Therapeutics Appoints Dr. David Steensma as Chief Medical Officer

Published: August 23, 2023

NEW YORK--(BUSINESS WIRE)--Aug 23, 2023--

Source: eagletribune.com
Related Topics:
United StatesKathryn MorrisDavid SteensmaRoss LevineMartin VogelbaumLaurence Joseph DineenEdwardp EvansDavidp SteensmaHarvard Medical SchoolTranslational ResearchDivision Of Hematological MalignanciesNovartis Institutes For Biomedical ResearchDana Farber Cancer InstituteDivision Of HematologyDepartment Of MedicineInstitute PhysicianDrug AdministrationUniversity Of Chicago Pritzker School MedicineOncology Drug Advisory CommitteeLeukemia ResearchAmerican Society Of HematologyAjax Therapeutics IncAdult Leukemia ProgramYates NetworkChief Medical
Vaxxas Opens World-Class Manufacturing Facility To Produce Proprietary Needle-Free Vaccine Patch For Late-Stage Clinical Trials and First Commercial Products - Vimarsana News

Vaxxas Opens World-Class Manufacturing Facility To Produce Proprietary Needle-Free Vaccine Patch For Late-Stage Clinical Trials and First Commercial Products

Published: June 18, 2023

CAMBRIDGE, Mass. & BRISBANE, Australia--(BUSINESS WIRE)--Vaxxas, a clinical-stage biotechnology company commercializing a novel vaccination platform technology, today announced the opening of its

Source: ibtimes.com.au
Related Topics:
United KingdomUnited StatesKathryn MorrisDavid HoeyAmy MillerDevelopment AuthorityEuropean Medicines AgencyOneventures Innovation FundEconomic Development QueenslandManufacturing InitiativeCoalition For Epidemic Preparedness InnovationsUniversity Of QueenslandMelinda Gates FoundationDrug AdministrationWorld Health OrganizationAustralian Government Innovation Investment FundYates NetworkAustralian Therapeutic Goods AdministrationUnited States Biomedical Advanced ResearchQueensland GovernmentGood Manufacturing PracticeVaxxas Biomedical FacilityAustralian GovernmentModern Manufacturing InitiativeDeputy Premier
Vaxxas Appoints Rochelle Chaiken, M.D., as Chief Medical Officer - Vimarsana News

Vaxxas Appoints Rochelle Chaiken, M.D., as Chief Medical Officer

Published: June 5, 2023

Industry veteran and senior medical leader from Pfizer brings deep global expertise as Vaxxas advances multiple clinical programs and moves toward commercialization.

Source: ibtimes.com.au
Related Topics:
United StatesUnited KingdomAmy MillerKathryn MorrisDavid HoeyRochelle ChaikenUniversity Of QueenslandUniversity Of RochesterBiopharmaceutical Group For EmergingEndocrinology Diabetes Metabolism At Harvard Medical SchoolAustralian Government Innovation Investment FundYates NetworkOneventures Innovation FundChief MedicalVaxxas Chief Executive Officer David HoeyChief Medical OfficerBiopharmaceutical GroupHarvard Medical SchoolBeth Israel HospitalClinical InvestigatorBrandon Capital PartnersBrandon BiocatalystHealthcare VenturesAustralian GovernmentInnovation Investment Fund